MARKET

SGP

SGP

SpyGlass Pharma, Inc.
NASDAQ
27.83
+1.65
+6.30%
Closed 18:55 02/10 EST
OPEN
26.35
PREV CLOSE
26.18
HIGH
28.05
LOW
25.40
VOLUME
101.14K
TURNOVER
--
52 WEEK HIGH
32.44
52 WEEK LOW
20.16
MARKET CAP
927.22M
P/E (TTM)
-9.7993
1D
5D
1M
3M
1Y
5Y
1D
Major Insider Moves Signal Growing Confidence in SpyGlass Pharma
TipRanks · 11h ago
Opening Day: SpyGlass Pharma soars in debut after strongly priced IPO
TipRanks · 1d ago
Weekly Report: what happened at SGP last week (0202-0206)?
Weekly Report · 2d ago
U.S. IPO Weekly Recap: 7 IPOs Make It One Of The Busiest Weeks In 4 Years
Seeking Alpha · 4d ago
SpyGlass Pharma surges on public debut; AgomAb falls
Seeking Alpha · 4d ago
BUZZ-U.S. STOCKS ON THE MOVE-SpyGlass, Agomab, Piper Sandler, Molina
Reuters · 4d ago
SpyGlass Pharma Stock Jumps in First Day of Trading
Dow Jones · 4d ago
BUZZ-SpyGlass surges in Nasdaq debut after $150 million IPO
Reuters · 4d ago
More
About SGP
SpyGlass Pharma Inc is a United States-based ophthalmic drug delivery company. The Company is focused on developing and commercializing long-term, drug delivery solutions for patients suffering from ophthalmic diseases. Its lead product candidate is SpyGlass Drug Delivery Platform with bimatoprost, which is designed to deliver three years of bimotic anti-inflammatory therapy to targeted tissues in the eye.

Webull offers SpyGlass Pharma, Inc. stock information, including NASDAQ: SGP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SGP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SGP stock methods without spending real money on the virtual paper trading platform.